Skip to Content

Procyon Corp PCYN

Morningstar Rating
$0.30 0.00 (0.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PCYN is trading at a 59% discount.
Price
$0.30
Fair Value
$2.66
Uncertainty
Extreme
1-Star Price
$9.25
5-Star Price
$6.50
Economic Moat
Jbvjr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PCYN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.30
Day Range
$0.300.30
52-Week Range
$0.150.31
Bid/Ask
$0.20 / $0.30
Market Cap
$2.42 Mil
Volume/Avg
160 / 9,115

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.51
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
19

Valuation

Metric
PCYN
Price/Earnings (Normalized)
Price/Book Value
0.98
Price/Sales
0.51
Price/Cash Flow
Price/Earnings
PCYN

Financial Strength

Metric
PCYN
Quick Ratio
2.47
Current Ratio
3.81
Interest Coverage
Quick Ratio
PCYN

Profitability

Metric
PCYN
Return on Assets (Normalized)
−2.32%
Return on Equity (Normalized)
−3.30%
Return on Invested Capital (Normalized)
−3.01%
Return on Assets
PCYN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ABdvz$90.3 Bil
MKKGY
Merck KGaA ADRWwlnvd$74.8 Bil
HLN
Haleon PLC ADRKsmc$38.3 Bil
VTRS
Viatris IncBwxn$16.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNsnn$12.9 Bil
CTLT
Catalent IncPnpdtf$10.6 Bil
PRGO
Perrigo Co PLCCwtp$4.4 Bil
CURLF
Curaleaf Holdings IncHfb$3.9 Bil
PBH
Prestige Consumer Healthcare IncYzzyxpl$3.5 Bil
GTBIF
Green Thumb Industries IncMvmv$3.4 Bil

Sponsor Center